Patent expiration of cholesterol-lowering medicines Zocor and Pravachol will put particular pressure on Pfizer 's (nyse: PFE - news - people ) Lipitor as health plans push their enrollees to use the copycat drugs instead.
FORBES: Robert Langreth On Health Care